EichorEICHOR
Location: Drammen Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Drammen

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Drammen Sykehus, Vestre Viken HF ( Site 2001) · Merck Sharp & Dohme LLC · NCT06393374
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or B
NA · Vestre Viken Health Trust · Vestre Viken Hospital Trust · NCT06197048
A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study
NA · Vestre Viken HF · Haukeland University Hospital · NCT05095571
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Drammen Sykehus, Vestre Viken HF · Eli Lilly and Company · NCT06890598
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Drammen Sykehus, Vestre Viken HF ( Site 1903) · Merck Sharp & Dohme LLC · NCT06077760
A Talus Implant in Patients Between 20-60 Years of Age Followed up for a Minimum of 2 Years After Surgery
NA · Drammen Sykehus · Vestre Viken Hospital Trust · NCT06932380
Management of Patients With Heart Failure at Home After Hospital Discharge
NA · Drammen Hospital, Vestre Viken HF · University Hospital, Akershus · NCT06576752
Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial
Phase 4 · Drammen Hospital · Oslo University Hospital · NCT06653634
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Drammen Sykehus, Vestre Viken HF · Eli Lilly and Company · NCT06119581
Strengthening Hope After ICU Discharge
NA · Vestre Viken HF, Bærum Hospital · Oslo University Hospital · NCT06569901
Comparing Enhanced Cognitive-behavior Therapy and Family-based Treatment for Adolescents With an Eating Disorder
NA · Vestre Viken Health Trust · Oslo University Hospital · NCT06256380
Wrist and Carpal Arthrodeses. A 1-year Follow-up Study.
Phase N/A · Drammen Sykehus · Vestre Viken Hospital Trust · NCT06917235
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · Local Institution - 007-310 · Mirati Therapeutics Inc. · NCT04613596
Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
Phase 3 · Vestre Viken Hospital Trust · Sven Löffeler · NCT05448547
Improving Public Cancer Care by Implementing Precision Medicine in Norway
Phase 2 · Vestre Viken Hospital · Oslo University Hospital · NCT04817956
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Parti
Phase 3 · Drammen Sykehus, Vestre Viken HF ( Site 2502) · Merck Sharp & Dohme LLC · NCT06312137
Positive Feeding of the Preterm Infant
NA · Vestre Viken Hospital Trust · Oslo Metropolitan University · NCT06189352
The Norwegian Antirheumatic Drug Register
Phase N/A · Vestre Viken HF Drammen Hospital · Diakonhjemmet Hospital · NCT01581294
The Norwegian Immunotherapy in Multiple Myeloma Study
Phase N/A · Drammen hospital · St. Olavs Hospital · NCT06855121
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus
Phase 2/Phase 3 · Local Institution - 0096 · Bristol-Myers Squibb · NCT07063745
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Phase 3 · Drammen Sykehus, Vestre Viken HF ( Site 3700) · Merck Sharp & Dohme LLC · NCT06966700
INTEgRated Health CARE for Patients With Frailty and Heart Failure
NA · Drammen Hospital · Vestre Viken Hospital Trust · NCT06444321
Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer
Phase 2 · Vestre Viken Health Trust · Vestre Viken Hospital Trust · NCT05344209
Cognitive Behavioural Therapy for Insomnia in Patients With Coronary Heart Disease
NA · Vestre Viken Trust Drammen hospital · Vestre Viken Hospital Trust · NCT06749951
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cel
Phase 3 · Seksjon for kreftbehandling, Drammen Hospital · Gilead Sciences · NCT06801834
Biology of Juvenile Myoclonic Epilepsy
Phase N/A · Vestre Viken Health Trust, Oslo · King's College London · NCT03400371
D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
Phase 2 · Vestre Viken Hospital · Haukeland University Hospital · NCT07312110
Health-Related Quality of Life in Children and Adolescents With Clubfoot
Phase N/A · Vestreviken · Vestre Viken Hospital Trust · NCT06906406
Exercise Training Study of Patients With Claudicatio Intermittens
NA · Vestre Viken, Drammen sykehus · Norwegian University of Science and Technology · NCT06448390
Antibiotic Therapy in Viral Airway Infections
Phase 4 · Drammen Hospital, Vestre Viken Hospital Trust · University Hospital, Akershus · NCT05045612
Look up another city
Look up another condition